Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.

In a poster at the 2022 SOC scientific symposium, Andrew Alexis, MD, MPH, examined the efficacy of one AD drug against race and ethnicity.

In this video interview, we sit down with Natasha Atanaskova Mesinkovska, MD, PhD, FAAD, to discuss her 2022 AAD annual meeting presentation on alopecia areata. We dive into pipeline possibilities, what current treatments are missing, and more.

In a presentation at the current AAD annual meeting, experts discussed differential diagnoses and clinical presentations in birthmarks and hamartomas.

Mariam Totonchy, MD, and Chrysalyne D. Schmults, MD, MSCE, discuss best practices when caring for high-risk cSCC patients, including surgical vs nonsurgical options, imaging, and follow-up protocol.

The American Academy of Dermatology Annual meeting starts today, offering presentations focusing on the latest treatment updates, new data, plus much more.

Today, the 18th Annual Skin of Color Scientific Symposium begins, showcasing new research in the field, key insights, and the evolution in skin of color dermatology.

The 3rd Annual San Diego Dermatology Symposium (SDDS) was held in-person for the first time on March 11 to 13, 2022, at the Hilton San Diego Bayfront, in California.

This weekend, March 11-13, 2022, the San Diego Dermatology Symposium (SDDS) will be educating physicians in person. Everything from traditional topics like atopic dermatitis to rare disease such as Stevens-Johnson syndrome will be covered.

Click here to answer this week's poll.

Timber Pharmaceuticals announced a positive end-of-phase 2 meeting with the FDA about TMB-001 in moderate to severe congenital ichthyosis. Timber also revealed when it plans to start a phase 3 trial.

Clinical trials investigate biologics, JAK inhibitors, and additional systemic treatments as first-line alternatives to or adjuvant therapies alongside surgery.

Poster presented at Maui Derm for Dermatologists 2022 reveals prognostic value of 2 independently validated algorithms.

Suneel Chilukuri, MD, discusses lower eyelid rejuvenation, including avoiding complications, in his presentation at the Maui Derm for Dermatologists meeting.

Suneel Chilukuri, MD, discusses new innovations in dermatology, including hyperpigmentation, in his presentation at the Maui Derm for Dermatologists meeting.

Robert S. Kirsner, MD, PhD, discusses new and tried-and-true wound healing methods in his presentation at the Maui Derm for Dermatologists meeting.

Improve patient outcomes in wound healing with the best practices of time-honored and cutting-edge approaches.

A poster presentation from Follica at the 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm for Dermatology meeting found that 56% of survey responders did not seek treatment for their hair loss, and that 19% of respondents who attempted treatment quit because of lack of efficacy or cost.

Linda Stein Gold, MD, discusses psoriasis in 2022, in her presentation at the current Maui Derm for Dermatologists meeting.

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.